Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-3020-01
Published October 10, 2012 · Recall initiated: June 28, 2012
Summary
FDA records drug Class III recall D-1703-2012, published October 10, 2012 and initiated June 28, 2012. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 31,867 Bottles; Lot: Lot: 3018952, Exp 08/12. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Impurities/Degradation Products: Out of specification results for Related Compound during routine stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Nationwide and PR
- Lot
- Lot: 3018952, Exp 08/12
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACandesartan Cilexetil and Hydrochlorothiazide Tablets, USP 32 mg/12.5 mg, packaged in a) 90-count bottles (NDCOctober 28, 2020
- FDATacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDCApril 1, 2020
- FDASotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WVMarch 25, 2020
- FDANizatidine Capsules, USP 150 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5150-91.January 29, 2020
- FDAChloraPrep One-Step (2% w/v chlorhexidine gluconate and 70% v/v isopropyl alcohol) Patient Preoperative SkinOctober 10, 2012
- FDALuna & Larry's Coconut Bliss Mocha Maca Crunch; UPC 8 96767 00143 1October 10, 2012
Questions about this recall
Was Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-3020-01 recalled?
Yes. FDA published recall D-1703-2012 on October 10, 2012. Reported hazard: Impurities/Degradation Products: Out of specification results for Related Compound during routine stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter